Showing results (711-720 of 2,281) with videos related to
Sort By:
Pageof 229
HIV Medicine|May 11, 2011
Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive AustraliansJ Grierson, R L Koelmeyer, A Smith, et al.HIV Medicine|April 27, 2011
Can community health workers improve adherence to highly active antiretroviral therapy in the USA? A review of the literatureS Kenya, N Chida, S Symes, et al.HIV Medicine|March 23, 2011
British HIV Association and Children's HIV Association position statement on infant feeding in the UK 2011G P Taylor, J Anderson, P Clayden, et al.HIV Medicine|February 24, 2006
Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998B Lebouché, Y Yazdanpanah, Y Gérard, et al.HIV Medicine|February 24, 2006
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wastingJ Gold, M J Batterham, H Rekers, et al.HIV Medicine|February 24, 2006
Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohortY Yuan, G L'italien, J Mukherjee, et al.HIV Medicine|February 24, 2006
Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unitR Palacios, A Hidalgo, C Reina, et al.HIV Medicine|January 20, 2006
Analysis of genotypic and phenotypic clinical cut-off levels for ritonavir-boosted saquinavirA Hill, S Walmsley, B Clotet, et al.HIV Medicine|September 5, 2025
Examination of factors associated with mental health of people living with HIV in Kazakhstan: A cross-sectional study based on the two-continua modelAdel Stoyanova, Faye Foster, Pavel Savin, et al.HIV Medicine|April 23, 2010
Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growthM J Sikora, J M Rae, M D Johnson, et al.Pageof 229